Status:

COMPLETED

Validation of Capnodynamic Assessment of Mixed Venous Oxygen Saturation

Lead Sponsor:

Karolinska Institutet

Conditions:

Cardiac Output, Low

Cardiac Output, High

Eligibility:

All Genders

Up to 18 years

Brief Summary

Mixed venous saturation (SvO2) is an indicator of the balance between oxygen supply and demand in the body's tissues Recently, our research team published a paper describing the possibility to continu...

Detailed Description

Background: Mixed venous saturation (SvO2) is an indicator of the balance between oxygen supply and demand in the body's tissues The primary objective of the current study is thus to investigate the a...

Eligibility Criteria

Inclusion

  • Patients undergoing percutaneous intervention of cardiac conditions such as closure of atrial septal defect, persistent ductus arteriosus, pulmonary artery stenosis and diagnostic catheterization after heart transplant.
  • \-

Exclusion

  • ongoing ECMO treatment or intracardiac shunts not subjected to intervention. Weight less than 3.5 kg. Single ventricle circulation.
  • \-

Key Trial Info

Start Date :

June 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2023

Estimated Enrollment :

29 Patients enrolled

Trial Details

Trial ID

NCT04885699

Start Date

June 1 2021

End Date

October 1 2023

Last Update

January 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Karolinska University Hospital

Stockholm, Sweden, 171 64